553
Views
11
CrossRef citations to date
0
Altmetric
Research Article

The Edinburgh Cognitive and Behavioral ALS screen: relationship to age, education, IQ and the Addenbrooke’s Cognitive Examination-III

, , &
Pages 585-590 | Received 02 Apr 2018, Accepted 10 Jun 2018, Published online: 29 Oct 2018

References

  • Abrahams S, Newton J, Niven E, Foley J, Bak T. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
  • Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.
  • Strong M, Abrahams S, Goldstein L, Woolley S, Mclaughlin P, Snowden J. Amyotrophic lateral sclerosis – frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontemporal Degener. 2017;18:153–74.
  • Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): A cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:172–9.
  • Pinto-Grau M, Burke T, Lonergan K, McHugh C, Mays I, Madden C, et al. Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:99–106.
  • Lulé D, Burkhardt C, Abdulla S, Böhm S, Kollewe K, Uttner I, et al. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: A cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:16–23.
  • Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:489–98.
  • Jeyapaul P, Kerwick S. Addenbrooke’s Cognitive Examination as a better discriminator of cognitive impairment than the Mini-mental State Examination in patients with dementia. Int Psychogeriatr. 2008;20:642–3.
  • Jubb M, Evans J. An investigation of the utility of the Addenbrooke’s Cognitive Examination III in the early detection of dementia in memory clinic patients aged over 75 years. Dement Geriatr Cogn Disord. 2015;40:222–32.
  • Matías-Guiu JA, Valles-Salgado M, Rognoni T, Hamre-Gil F, Moreno-Ramos T, Matías-Guiu J. Comparative Diagnostic Accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for Screening of Alzheimer Disease. Dement Geriatr Cogn Disord. 2017;43:237–46.
  • Lees RA, Hendry BA K, Broomfield N, Stott D, Larner AJ, Quinn T. Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items. Int J Geriatr Psychiatry. 2017;32:1072–8.
  • Davies RR, Dawson K, Mioshi E, Erzinçlioğlu S, Hodges JR. Differentiation of semantic dementia and Alzheimer’s disease using the Addenbrooke’s Cognitive Examination (ACE). Int J Geriat Psychiatry. 2008;23:370–5.
  • McColgan P, Evans JR, Breen DP, Mason SL, Barker RA, Williams-Gray CH. Addenbrooke’s Cognitive Examination-Revised for mild cognitive impairment in Parkinson’s disease. Mov Disord. 2012;27:1172–6.
  • Velayudhan L, Ryu S-H, Raczek M, Philpot M, Lindesay J, Critchfield M, et al. Review of brief cognitive tests for patients with suspected dementia. Int Psychogeriatr. 2014;26:1247–62.
  • Newman CGJ, Bevins AD, Zajicek JP, Hodges JR, Vuillermoz E, Dickenson JM, et al. Improving the quality of cognitive screening assessments: ACEmobile, and iPad-based version of the Addenbrooke’s Cognitive Examination-III. Alzheimers Dement (Amst). 2018;10:182–7.
  • Morris RG, Brookes RL. Neuropsychological Assessment of Older Adults. In: Goldstein LH, McNeil JE, eds. Clinical Neuropsychology: A Practical Guide to Assessment and Management for Clinicians. 2nd ed., Chichester, West Sussex: John Wiley & Sons; 2013:347–73.
  • Yoshida H, Terada S, Honda H, Ata T, Takeda N, Kishimoto Y, et al. Validation of Addenbrooke’s cognitive examination for detecting early dementia in a Japanese population. Psychiatry Res. 2011;185:211–4.
  • Bier JC, Ventura M, Donckels V, Van Eyll E, Claes T, Slama H, et al. Is the Addenbrooke’s Cognitive Examination effective to detect frontotemporal dementia? J Neurol. 2004;251:428–31.
  • Elamin M, Holloway G, Bak TH, Pal S. The utility of the Addenbrooke’s cognitive examination version three in early-onset dementia. Dement Geriatr Cogn Disord 2015;41:9–15.
  • Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke’s Cognitive Examination III in Frontotemporal Dementia and Alzheimer’s Disease. Dement Geriatr Cogn Disord. 2013;36:242–50.
  • Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.
  • Loose M, Burkhardt C, Aho-Özhan H, Keller J, Abdulla S, Böhm S, et al. Age and education-matched cut-off scores for the revised German/Swiss-German version of ECAS. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:374–6.
  • Ye S, Ji Y, Li C, He J, Liu X, Fan D. The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese amyotrophic lateral sclerosis population. Plos One. 2016;11:e0155496.
  • Cohen J. Statistical Power Analysis for the Behavioural Sciences. Hillside, NJ; Hove: Lawrence Erlbaum; 1988:287, 478.
  • Field A. Discovering Statistics using SPSS. 3rd ed. London, UK: SAGE; 2009;69:115.
  • Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behaviour, and biomedical sciences. Behav Res Methods. 2007;39:175–91.
  • Noone P. The Addenbroke’s Cognitive Examination-III. Occmed. 2015;65:418–20.
  • Wechsler D. Wechsler Abbreviated Scale of Intelligence. 2nd ed. San Antonio, TX: Pearson;2011.
  • Office for National Statistics (2010) SOC2010 volume 3: the National Statistics Socio-economic classification (NS-SEC rebased on SOC2010) http://webarchive.nationalarchives.gov.uk/20160105160709/http://www.ons.gov.uk/ons/guide-method/classifications/current-standard-classifications/soc-2010/soc2010-volume-3-ns-sec–rebased-on-soc2010–user-manual/index.html. Accessed October 31, 2016.
  • Colosimo C, Bak TH, Bologna M, Berardelli A. Fifty years of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 2014;85:938–44.
  • Bak TH, Hodges JR. (2008) Corticobasal Degeneration: clinical aspects. In: Duyckaerts C, Litvan I, eds. Handbook of Clinical Neurology. Amsterdam, Elsevier; 2009:509–21.
  • Ganguli M, Lytle ME, Reynolds MD, Dodge HH. Random versus volunteer selection for a community-based study. J Gerontol Med Sci. 1998;53A:M39–46.
  • Henrich J, Heine SJ, Norenzayan A. The weirdest people in the world? Behav Brain Sci. 2010;33:61–135.
  • Arnett B, Rikli R. Effects of method of subject selection (volunteer vs random) and treatment variable on motor performance. Res Quart Exerc Sport. 1981;52:433–40.
  • Wrights AP, Fain CW, Miller ME, Rejeski WJ, Williamson JD, Marsh AP. Assessing physical and cognitive function of older adults in continuing care retirement communities: Who are we recruiting? Contemp Clin Trials. 2015;40:159–65.
  • Prince M, Knapp M, Guerchet M, McCrone M, Prina P, et al. Dementia UK: Update Second Edition report produced by King’s College London and the London School of Economic for the Alzheimer’s Society; 2014:61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.